Literature DB >> 7569474

The concept of individualized hypertension care in general practice and outpatient clinics. The general practitioner hypertension practice study (III).

M Ribacke1.   

Abstract

OBJECTIVE: To examine test ordering practice among general practitioners and hospital medical specialists according to the concept of individualized hypertension care.
DESIGN: Mailed hypothetical case histories, with reference panels to categorize tests.
SETTING: Uppsala-Orebro region in mid-Sweden.
SUBJECTS: General practitioners (N = 90) and hospital medical specialists (N = 69) in randomly sampled primary health care centres and hospitals. MAIN OUTCOME MEASURES: Test ordering scores.
RESULTS: 84% of invited GPs and 72% of specialists participated. According to reference panel standards, primary care physicians performed 75% of obligatory tests and specialists 88%. Superfluous tests constituted a larger proportion of the practice of hospital specialists (11-28%) than GPs (2-12%) in the six cases. Summarized examination scores revealed a wide practice variation within and between the two physician categories, specialists scoring significantly higher in three cases. Standardization of practice was more common among specialists, and differed significantly regarding serum potassium test, chest X-ray and ECG. Both groups deviated from current guidelines by omitting metabolic parameters.
CONCLUSION: There is considerable practice variation in individualized hypertension care, which might influence treatment outcome. Practice audit and continuing medical education could contribute to care standardization according to guidelines.

Entities:  

Mesh:

Year:  1995        PMID: 7569474     DOI: 10.3109/02813439508996746

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  1 in total

1.  Contemporary practice patterns in the management of newly diagnosed hypertension.

Authors:  F A McAlister; K K Teo; R Z Lewanczuk; G Wells; T J Montague
Journal:  CMAJ       Date:  1997-07-01       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.